Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REST: Safety and Efficacy of RotaTeq in Healthy Infants
NCT00090233Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2001
- Primary completion
- Oct 2004
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of rotavirus vaccine, live, oral, pentavalent in rotavirus gastroenteritis, sponsored by Merck & Co.. Started Jan 2001; status: completed.
02
Drugs
rotavirus vaccine, live, oral, pentavalent
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT00090233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00090233.